Interagency Oncology Task Force Fellowship
The Interagency Oncology Task Force Fellowship (IOTF) program trains scientists in research and research-related regulatory review, policies, and regulations to develop a skill set that bridges the two disparate processes. Fellows learn to build awareness of regulatory requirements into the early stages of the medical product development process and will develop strategies to improve planning throughout research and regulatory review.
The fellowship is offered as a partnership of the National Cancer Institute (NCI), National Institutes of Health (NIH), and U.S. Food and Drug Administration (FDA), and the U.S. Department Health and Human Services (HHS).
*Selection of fellows will be dependent upon the availability of funds. Note eligibility requirement for all IOTF tracks: U.S. citizenship or permanent residents, who have resided in the US for a total of three of the past five years.
The application cycle will open on May 1st, 2023 and close on June 5th, 2023. The program will start on September 1st, 2023.
IOTF Program Tracks
- Track 1: Oncology Product Research and Review for M.D. Oncology Fellows
This fellowship will train physicians in aspects of clinical trials methodology and analysis, epidemiology, clinical aspects of medical product development, and regulation to facilitate the movement of drugs, biologics, and devices from the basic bench science to commercialization.
- Track 2: Oncology Product Research and Review for B.C. Oncologists
This fellowship will train physicians in aspects of drug, biologic, or device development and related issues and standards to facilitate movement from basic bench science to commercialization.
- Track 3: Oncology Product Research and Review for Postdoctoral Research Fellows
This fellowship will train individuals with postdoctoral research experience in aspects of research and review of the medical product development process to facilitate the movement of drugs, biologics, and devices from the bench to the bedside.
- Track 4: Cancer Prevention Product Research and Review
This fellowship will train individuals in aspects of the cancer prevention drug, biologic, or device development processes, including their application to study populations, to facilitate the movement of novel approaches from the bench to the community.
Current and Alumni Fellows
Meet the current and alumni IOTF fellows. Learn how IOTF relates to fellows' professional background, research interests, and career goals.
Chanelle Case Borden, Ph.D.
IOTF Program Manager
National Cancer Institute
9609 Medical Center Drive
Bethesda, MD 20892-9707
U.S. Food and Drug Administration (FDA)
Office of Scientific Professional Development
Building 1, Room 4345
OMB No.: 0925-0761
Expiration Date: 07/31/2025
Public reporting burden for this collection of information is estimated to average 60 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing he collection of information. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to: NIH, Project Clearance Branch, 6705 Rockledge Drive, MSC 7974, Bethesda, MD 20892-7974, ATTN: PRA (0925-0761). Do not return the completed form to this address.